Edwards Lifesciences Corp

Exchange: NYSESector: HealthcareIndustry: Medical Devices

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Did you know?

A large-cap company with a $47.3B market cap.

Current Price

$81.53

+2.28%

GoodMoat Value

$55.68

31.7% overvalued

Profile

Valuation (TTM)

Market Cap$47.29B

P/E44.05

EV$44.05B

P/B4.57

Shares Out580.00M

P/Sales7.79

Revenue$6.07B

EV/EBITDA29.31

Edwards Lifesciences Corp (EW) Stock News

Macro Pulse mentions

View full macro archive →

EW Latest News

EW Stock News & Headlines

Latest stock news and headlines for Edwards Lifesciences Corp (EW). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.

Current stock price: $81.53. Market cap: $47.29B. Sector: Healthcare. Industry: Medical Devices. This page aggregates the latest news articles relevant to EW from financial news sources, helping investors stay current on events that may impact Edwards Lifesciences Corp's stock price.

News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Edwards Lifesciences Corp (EW).